Skip to main content
Premium Trial:

Request an Annual Quote

Fisher s Q3 Revenues Grow 13 Percent as Profit More Than Doubles

NEW YORK, Nov. 9 (GenomeWeb News) - Fisher Scientific today reported a 13-percent increase in revenues, and more than doubled its net income for the three months ended Sept. 30.

 

Fisher's revenues for the third quarter rose to $1.4 billion from $1.26 billion in the same period a year ago.

 

Net income also surged to $94 million, or $0.77 per basic share, from $36 milllion, or $0.36 per basic share in the year-ago period.

 

Fisher Scientific had approximately $189.2 million in cash and cash investments as of Sept. 30.

 

The company did not report R&D expenditures for the quarter.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.